Company news
Easton Pharmaceuticals Inc (OTC:EAPH) news
Easton Pharmaceuticals Inc news releases on 6ix. Latest, Nov 20, 2019: SEC Suspension of Trading
Press releases & updates
SEC Suspension of Trading
November 20, 2019
Easton Pharmaceuticals Turns to Profit in Q1, Provides Business Update
June 13, 2019
Easton Announces That it Is Moving its Corporate Office After the Purchase of its Food Processing Company Specializing in Baked Goods and the Launch of its New Website
April 29, 2019
Easton Closes Purchase of Food Processing Company Specializing in Baked Goods with Projected Revenues Over $20,000,000 per Year and Positioned to Enter the Cannabis Edibles Market
April 23, 2019
Easton Provides Update on the Closing of its Agreement To Acquire Commercial Bakery
April 11, 2019
Easton Provides Update on the Closing of its Agreement To Acquire Commercial Bakery with Projected Revenues Over $20,000,000 per Year and Positioned to Enter the Cannabis Edibles Market
April 7, 2019
Easton Announces Signing of Joint Venture Agreement for the Purchase and Development of 9 Townhomes with Revenue in Excess of $4 Million and Provides Update on its Framing Contract with Revenues of $770K for Q1
April 1, 2019
Easton Signs LOI with Licensed Producer of Cannabis to Expand its Operations and Participate in its Cannabis Edibles Division
March 26, 2019
Easton Announces Filing of Its Financial Statements for the Year Ended December 31, 2018 with a Revenue Increase of 145% Over 2017 and Provides General Business Update
March 17, 2019
Easton Announces Status Update On Its $2,600,000 Framing Contract To Construct 150 Homes, Including Update on Its Development Project in Cobourg, Ontario
March 12, 2019
Easton Commences Cannabis Edibles Division and Announces Updates on Its Filing for the Period Ended December 31, 2018
March 10, 2019
Easton Signs Agreement to Acquire Commercial Bakery with Projected Revenues Over $20,000,000 per Year and Positioned to Enter the Cannabis Edibles Market
March 5, 2019
Easton Signs Agreement to Acquire Commercial Bakery with Projected Revenues Over $20,000,000 per Year And Positioned to Enter the Cannabis Edibles Market
March 4, 2019
Easton Announces Updates on Its $2,600,000 Framing Contract to Construct 150 Homes as Well as Other Initiatives
February 5, 2019
Easton Pharmaceuticals Is Short-Listed to Acquire an Interest in an Operating Casino and Hotel Resort in Loutraki, Greece with Revenues in Excess of 60 Million Euro Per Year
October 1, 2018
Easton Pharmaceuticals Reaches Agreement to Take Over Hotel and $17,000,000 Real Estate Asset in Heart of Toronto, Canada
September 27, 2018
Easton Pharmaceuticals Announces It Has Entered Into High Level Negotiations To Take Over a Profitable Hotel and a $17,000,000 Real Estate Asset Located In The Heart of Toronto, Ontario, Canada
September 11, 2018
Easton Pharmaceuticals to Participate in a Casino and Hotel Resort Project in Europe with Projected Revenues in Excess of 77 Million Euro Per Annum
August 29, 2018
Easton Pharmaceuticals Begins Discussions to Acquire an Interest in an Operating Casino and Hotel Resort in Greece with Revenues in Excess of 60 Million Euro Per Year
August 22, 2018
Easton Pharmaceuticals Acquires Interest in Development Project With in Excess of $30 Million in Profit
August 20, 2018
CORRECTION: Easton Acquires Interest in Development Project with in Excess of $30 Million in Profit
August 19, 2018
Easton Acquires Interest in Development Project
August 19, 2018
Easton Pharmaceuticals Inc. Announces the Departure of its Recently Appointed Director
August 12, 2018
Easton’s JV Georgina Property Resumes Operations. Revenues Expected to be in-line with Estimates for the End of the Year
July 26, 2018
Easton Pharmaceuticals Strengthens its Board of Directors While Enhancing Existing Businesses and Moves Towards New Sectors and Industries
June 25, 2018
Easton Pharmaceuticals Announces New Director / Officer to Its Board and Updates to Business Direction
June 20, 2018
Easton Pharmaceuticals Announces That Easton and Its JV Partner, Alliance Group, Have Generated $40,000 in Revenues in the First Week of Operations
June 11, 2018
Easton Pharmaceuticals Announces That Revenue Generating Operations Have Commenced From Its Alliance Property and Businesses
June 4, 2018
Easton Pharmaceuticals Announces it is Moving Towards a Letter of Intent With an AMPR Applicant Towards a Marijuana Cultivators / Growers License for Canada; Provides Other Updates
April 17, 2018
Easton Pharmaceuticals Announces BAYER Agreement Update
April 16, 2018
Easton Pharmaceuticals Announces Development of a Blockchain and Cryptocurrency Initiative
March 21, 2018
Easton Pharmaceuticals Announces It Has Commenced Negotiations With An AMPR Applicant Towards a Marijuana Cultivators / Growers License For Canada; Provides iBliss Update
March 14, 2018
Easton Pharmaceuticals Announces Key Management Addition With the Appointment of Dr. Daniel Bagi, M.D. to the Board of Directors; Provides Other Updates
February 20, 2018
Easton Pharmaceuticals Announces Negotiations for a New Sub-Distribution Agreement for One of Its Woman’s Diagnostic / Treatment Products & Provides Update on Its Alliance Operations
February 6, 2018
Easton Pharmaceuticals Announces The Signing Of Closed Sub-Distribution Agreement for Product VS-Sense
January 25, 2018
Easton Pharmaceuticals Announces the Appointment of Mr. Luigi Gentile as Director and Officer to the Company
January 10, 2018
Easton Pharmaceuticals & Partner BMV Medica Announce Delivery and Launch of AmnioSense (AL-Sense) in Mexico; Delivery Date for Purchase Order From Windsor Pharmaceuticals for Central America
December 6, 2017
Easton Pharmaceuticals / Alliance Group Awaits Equipment Delivery, Days Away From Commencing Operations On Its Aggregate Contract After Closing $1.3 Million JV Agreement For 50% Property Ownership Interest and Various Businesses
November 28, 2017
Easton Pharmaceuticals Announces Final Payment Completing $1.3 Million JV Agreement With Alliance Group For a 50% Property Ownership Interest and Various Businesses Including The Cultivation of Medical / Recreational Marijuana For National Canadian Market
October 20, 2017
Easton Pharmaceuticals & JV Partner Alliance Group Announces It Has Cleared Final Hurdles Toward Allowing For The Cultivation of Medical / Recreational Marijuana For National Canadian Market
October 10, 2017
Easton Pharmaceuticals Announces That Its Partner Windsor Pharmaceuticals Has Received Regulatory Approvals For Products VS-Sense and AL-Sense For Central America and The Caribbean
September 12, 2017
Easton Pharmaceuticals Announces $1,000,000 cdn In Payments Toward Alliance Group JV / Partnership Agreement; Announces $8,000,000 cdn Aggregate LOI Contract
September 5, 2017
Easton Pharmaceuticals and Alliance Group Announces the Closing Of Its First Aggregate Contract Valued At $6,000,000 CDN On Its 90 Acre Portion Of Industrial Zoned Land
August 23, 2017
Easton Pharmaceuticals Announces Advancing $575,000 Payment Towards Closed Agreement With Alliance Group For The Cultivation Of Medical / Recreational Marijuana For Canada and Other Revenue Producing Businesses
August 16, 2017
Easton Pharmaceuticals Announces Finalized Sub-Distribution Agreement With Gedeon Richter S.A.P.I de C.V. For Product Launch Of AmnioSense (AL-Sense)
August 10, 2017
Easton Pharmaceuticals Provides Shareholder Update On Acquisitions, Its Recent MMJ Initiative And Progress On Its Woman's Diagnostics and Treatment Segment
July 24, 2017
Easton Pharmaceuticals Announces It Has Received $400,000 USD In Product Purchase Orders For The Current Quarter From Its Woman's Diagnostic And Treatment Products Business For The Mexico Market
June 26, 2017
Easton Pharmaceuticals Announces It Has Finalized Agreement Terms With Alliance Group For Ownership Stake in Several Businesses On 45 Acres Of Agricultural Land, Which Includes The Cultivation of Medical Marijuana For National Canadian Market
June 12, 2017
Easton Pharmaceuticals Announces It Has Signed an LOI to Acquire An Interest in a 45 Acre Parcel for the Cultivation of Medical Marijuana in Toronto, Canada; Wholly Owned Subsidiary, iBliss in Birmingham's UK Vaper Expo
May 24, 2017
Easton Pharmaceuticals Announces Formally Accepting Proposal For The Sub-Licensing Of Product VS-Sense From German based Multi-National Pharmaceutical Company For Mexico; Agreement Includes An Up-Front Cash Payment And a Recurring Royalty
May 15, 2017